Alzheimer's Disease

Download as rtf, pdf, or txt
Download as rtf, pdf, or txt
You are on page 1of 11

Alzheimer's disease - Group 2

Anuradhabhavani Msc Medical Psychology

Introduction

• Alzheimer’s disease is an irreversible, progressive brain disorder that slowly


destroys memory and thinking skills, and, eventually, the ability to carry out the
simplest tasks. In most people with Alzheimer’s, symptoms first appear in their 30s
and mid-60s.

• Originally described by Dr. Alois Alzheimer in 1907, Alzheimer disease (AD) is


the most common cause of dementia.

• AD is defined pathologically by plaques and neurofibrillary tangles (NFT) in the


cerebral cortex. Plaques and tangles are associated with synaptic dysfunction,
neuronal degeneration, and progressive cognitive decline (AD dementia).

History of Alzheimer’s disease

Alzheimer’s disease is named after Dr. Alois Alzheimer. In 1906, Dr.


Alzheimer noticed changes in the brain tissue of a woman who had died of an
unusual mental illness. Her symptoms included memory loss, language problems,
and unpredictable behavior. After she died, he examined her brain and found many
abnormal clumps (now called amyloid plaques) and tangled bundles of fibers (now
called neurofibrillary, or tau, tangles).

Onset of Alzheimer’s disease

Damage occurring in the brain of someone with Alzheimer’s disease begins


to show itself in very early clinical signs and symptoms. For most people with
Alzheimer’s—those who have the late-onset variety—symptoms first appear in
their mid-60s. Signs of early-onset Alzheimer’s begin between a person’s 30s and
mid-60s.

Signs and symptoms of Alzheimer’s diease

• Memory problems are typically one of the first signs of cognitive impairment
related to Alzheimer’s disease. Some people with memory problems have a
condition called mild cognitive impairment (MCI). In MCI, people have more
memory problems than normal for their age, but their symptoms do not interfere
with their everyday lives.

• Movement difficulties and problems with the sense of smell have also been
linked to MCI. Older people with MCI are at greater risk for developing
Alzheimer’s, but not all of them do. Some may even go back to normal cognition.

• The first symptoms of Alzheimer’s vary from person to person. For many, decline
in non-memory aspects of cognition, such as word-finding, vision/spatial issues,
and impaired reasoning or judgment, may signal the very early stages of
Alzheimer’s disease.

• Memory loss: A person may have difficulty taking in new information and
remembering information. This can lead to:

• repeating questions or conversations

• losing objects

• forgetting about events or appointments

• wandering or getting lost

• Cognitive deficits: A person may experience difficulty with reasoning, complex


tasks, and judgment. This can lead to:

• a reduced understanding of safety and risks

• difficulty with money or paying bills

• difficulty making decisions

• difficulty completing tasks that have several stages, such as getting dressed

• Problems with recognition: A person may become less able to recognize faces or
objects or less able to use basic tools. These issues are not due to problems with
eyesight.

• Problems with spatial awareness: A person may have difficulty with their balance,
trip over, or spill things more often, or they may have difficulty orienting clothing
to their body when getting dressed.
• Problems with speaking, reading, or writing: A person may develop difficulties
with thinking of common words, or they may make more speech, spelling, or
writing errors.

• Personality or behavior changes: A person may experience changes in personality


and behavior that include:

• becoming upset, angry, or worried more often than before

• a loss of interest in or motivation for activities they usually enjoy

• a loss of empathy

• compulsive, obsessive, or socially inappropriate behavior.

Priyanka.S Msc Medical Psychology

Stages and Causes of Alzheimer's disease

Stage 1: No Impairment

During this stage, Alzheimer’s is not detectable and no memory problems or


other symptoms of dementia are evident.

Stage 2: Very Mild Decline

The senior may notice minor memory problems or lose things around the
house, although not to the point where the memory loss can easily be distinguished
from normal age-related memory loss. The person will still do well on memory
tests and the disease is unlikely to be detected by loved ones or physicians

Stage 3: Mild Decline

At this stage, the family members and friends of the senior may begin to
notice cognitive problems. Performance on memory tests are affected and
physicians will be able to detect impaired cognitive function.

People in stage 3 will have difficulty in many areas including:


· Finding the right word during conversations
· Organizing and planning
· Remembering names of new acquaintances
· People with stage three Alzheimer’s may also frequently lose personal
possessions, including valuables.

Stage 4: Moderate Decline

In stage four of Alzheimer’s, clear-cut symptoms of the disease are apparent.


People with stage four of Alzheimer’s:

· Have difficulty with simple arithmetic


· Have poor short-term memory (may not recall what they ate for breakfast,
for example)
· Inability to manage finance and pay bills
· May forget details about their life histories

Stage 5: Moderately Severe Decline

During the fifth stage of Alzheimer’s, people begin to need help with many day-to-
day activities. People in stage five of the disease may experience:

· Difficulty dressing appropriately

· Inability to recall simple details about themselves such as their own phone
number

· Significant confusion

On the other hand, people in stage five maintain functionality. They typically can
still bathe and toilet independently. They also usually still know their family
members and some detail about their personal histories, especially their childhood
and youth.
Stage 6: Severe Decline

People with the sixth stage of Alzheimer’s need constant supervision and
frequently require professional care. Symptoms include:

· Confusion or unawareness of environment and surroundings


· Inability to recognize faces except for the closest friends and relatives
· Inability to remember most details of personal history
· Loss of bladder and bowel control
· Major personality changes and potential behavior problems
· The need for assistance with activities of daily living such as toileting and
bathing
· Wandering
Stages 7: Very Severe Decline

Stage seven is the final stage of Alzheimer’s. Because the disease is a


terminal illness, people in stage seven are nearing death. In stage seven of the
disease, people lose the ability to communicate or respond to their environment.
While they may still be able to utter words and phrases, they have no insight into
their condition and need assistance with all activities of daily living. In the final
stages of Alzheimer’s, people may lose their ability to swallow.

CAUSES

Alzheimer's disease is thought to be caused by the abnormal build-up of


proteins in and around brain cells.One of the proteins involved is called amyloid,
deposits of which form plaques around brain cells.The other protein is called tau,
deposits of which form tangles within brain cells.

Although it's not known exactly what causes this process to begin, scientists
now know that it begins many years before symptoms appear.
early low in the brains of people with Alzheimer's disease.

Over time, different areas of the brain shrink. The first areas usually affected
are responsible for memories.

RISK FACTORS

Although it's still unknown what triggers Alzheimer's disease, several factors are
known to increase your risk of developing the condition.

Age

Age is the single most significant factor. The likelihood of developing


Alzheimer's disease doubles every 5 years after you reach 65.

This is called early- or young-onset Alzheimer's disease and it can affect people
from around the age of 40.

Family history

The genes you inherit from your parents can contribute to your risk of
developing Alzheimer's disease. But in a few families, Alzheimer's disease is
caused by the inheritance of a single gene and the risks of the condition being
passed on are much higher.

Down's syndrome

People with Down's syndrome are at a higher risk of developing Alzheimer's


disease.

This is because the genetic fault that causes Down's syndrome can also cause
amyloid plaques to build up in the brain over time, which can lead to Alzheimer's
disease in some people.

Head injuries

People who have had a severe head injury may be at higher risk of
developing Alzheimer's disease, but much research is still needed in this area.
Cardiovascular disease

Research shows that several lifestyle factors and conditions associated with
cardiovascular disease can increase the risk of Alzheimer's disease.

These include:

· smoking
· obesity
· diabetes
· high blood pressure
· high cholesterol

Other risk factors

In addition, the latest research suggests that other factors are also important,
although this does not mean these factors are directly responsible for causing
dementia.

These include:

· hearing loss
· untreated depression (though depression can also be one of the symptoms of
Alzheimer's disease)
· loneliness or social isolation
· a sedentary lifestyle

Srisanthiya.R Msc Medical Psychology

How to Diagnosis Alzheimer's disease

Doctors use several methods and tools to help determine whether a person
who is having memory problems has “possible Alzheimer’s dementia” (dementia
may be due to another cause) or “probable Alzheimer’s dementia” (no other
cause for dementia can be found).

To diagnose Alzheimer’s, doctors may:

· Ask the person and a family member or friend questions about overall
health, use of prescription and over-the-counter medicines, diet, past medical
problems, ability to carry out daily activities, and changes in behavior and
personality

· Conduct tests of memory, problem solving, attention, counting, and language

· Carry out standard medical tests, such as blood and urine tests, to identify
other possible causes of the problem

· Perform brain scans, such as computed tomography (CT), magnetic


resonance imaging (MRI), or positron emission tomography (PET), to rule
out other possible causes for symptoms

These tests may be repeated to give doctors information about how the person’s
memory and other cognitive functions are changing over time.

Alzheimer’s disease can be definitely diagnosed only after death, by linking


clinical measures with an examination of brain tissue in an autopsy.

People with memory and thinking concerns should talk to their doctor to
find out whether their symptoms are due to Alzheimer’s or another cause, such as
stroke, tumor, Parkinson’s disease, sleep disturbances, side effects of medication,
an infection, or a non-Alzheimer’s dementia. Some of these conditions may be
treatable and possibly reversible.

If the diagnosis is Alzheimer’s, beginning treatment early in the disease


process may help preserve daily functioning for some time, even though the
underlying disease process cannot be stopped or reversed. An early diagnosis also
helps families plan for the future. They can take care of financial and legal matters,
address potential safety issues, learn about living arrangements, and develop
support networks.
In addition, an early diagnosis gives people greater opportunities to
participate in clinical trials that are testing possible new treatments for Alzheimer’s
disease or other research studies.

Treatment

Alzheimer’s disease is complex, and it is unlikely that any one drug or other
intervention can successfully treat it. Current approaches focus on helping people
maintain mental function, manage behavioral symptoms, and slow down certain
problems, such as memory loss. Researchers hope to develop therapies targeting
specific genetic, molecular, and cellular mechanisms so that the actual underlying
cause of the disease can be stopped or prevented.

Medications to Maintain Mental Function in Alzheimer's Disease

Several medications are approved by the U.S. Food and Drug Administration
(FDA) to treat symptoms of Alzheimer’s. Donepezil (Aricept®), rivastigmine
(Exelon®), and galantamine (Razadyne®) are used to treat mild to moderate
Alzheimer’s (donepezil can be used for severe Alzheimer’s as well). Memantine
(Namenda®), the Exelon® patch, and Namzaric® (a combination of memantine
and donepezil) are used to treat moderate to severe Alzheimer’s. These drugs
work by regulating neurotransmitters, the chemicals that transmit messages
between neurons. They may help reduce symptoms and help with certain
behavioral problems. However, these drugs don’t change the underlying disease
process. They are effective for some but not all people, and may help only for a
limited time.

Medications to Manage Behavior in Alzheimer's Disease

Common behavioral symptoms of Alzheimer’s include sleeplessness,


wandering, agitation, anxiety, and aggression. Scientists are learning why these
symptoms occur and are studying new treatments—drug and non-drug—to manage
them. Research has shown that treating behavioral symptoms can make people
with Alzheimer’s more comfortable and makes things easier for caregivers.

Looking for New Treatments for Alzheimer's Disease

Alzheimer’s research has developed to a point where scientists are exploring


ways to delay or prevent the disease as well as treat its symptoms. In ongoing
clinical trials supported by NIA, scientists are developing and testing several
possible interventions. Under study are drug therapies aimed at a variety of targets,
including the beta-amyloid protein, cerebrovascular function, loss of synapses, and
specific neurotransmitters, as well as nondrug interventions, such as physical
activity, diet, cognitive training, and combinations of these approaches.

Support for Families and Alzheimer's Disease Caregivers

Caring for a person with Alzheimer’s disease can have high physical,
emotional, and financial costs. The demands of day-to-day care, changes in family
roles, and decisions about placement in a care facility can be difficult. There are
several evidence-based approaches and programs that can help, and researchers are
continuing to look for new and better ways to support caregivers.

Becoming well-informed about the disease is one important long-term


strategy. Programs that teach families about the various stages of Alzheimer’s and
about ways to deal with difficult behaviors and other caregiving challenges can
help.

Good coping skills, a strong support network, and respite care are other
ways that help caregivers handle the stress of caring for a loved one with
Alzheimer’s disease. For example, staying physically active provides physical and
emotional benefits.

Some caregivers have found that joining a support group is a critical lifeline.
These support groups allow caregivers to find respite, express concerns, share
experiences, get tips, and receive emotional comfort. Many organizations sponsor
in-person and online support groups, including groups for people with early-stage
Alzheimer’s and their families.

You might also like